Search results
Andrea Di Lenarda
Research Area(s) / Expertise:
Author
Author(s):
Andrea Barucci
,
Valentina Colcelli
,
Salvatore De Masi
,
et al
Added:
1 week ago
Author(s):
Mayra Guerrero
Added:
2 months ago
Gain essential insights into the pivotal trials and procedural techniques shaping transcatheter mitral valve replacement with Dr Mayra GuerreroThis presentation, part of Women As One's comprehensive Structural Interventions track, provides timely analysis of the landmark SUMMIT and ENCIRCLE trials that are defining the future of dedicated mitral devices.Drawing from clinical trial data showing…
View more
Author(s):
Rajesh Kharbanda
Added:
8 months ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Author(s):
Carla Agiatiello
Added:
4 months ago
Discover essential imaging techniques that drive successful interventions in the brachiocephalic trunk with Dr Carla AgatielloThis interactive presentation explores the critical role of multimodality imaging in contemporary structural heart procedures, providing cardiologists with the technical expertise needed for optimal procedural planning and guidance.Dr Agatiello addresses the integration of…
View more
Author(s):
Mohamed Marwan
Added:
4 months ago
Master the technical complexities of TAVR-in-TAVR procedures with Dr Mohamed MarwanThis essential presentation tackles implanting a transcatheter valve within a previously implanted, failing TAVR device. As first-generation TAVR patients return for treatment, Dr Marwan provides the critical knowledge needed to master these increasingly common complex procedures.Key technical considerations…
View more
Daniel A. Cehic
Research Area(s) / Expertise:
Job title: Chief Medical Officer
Author
Author(s):
Added:
8 months ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2…
View more
Thomas J Povsic
Job title: Assistant Professor of Medicine, Interventional Cardiologist, and Chief of the Endothelial Progenitor Cell Laboratory
Author
W Douglas Weaver
Job title: Consultant, New Product Development
Author